| 30/09/26 | 13:00:00 | 30 Sept 2026 | | Interim Results for the Six Months to June 30, 2026, and Business Update | GNW |
| 25/09/26 | 07:00:00 | 25 Sept 2026 | | The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer | GNW |
| 16/09/26 | 16:00:00 | 16 Sept 2026 | | Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial | GNW |
| 14/09/26 | 07:00:00 | 14 Sept 2026 | | Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee | GNW |
| 08/07/26 | 07:00:00 | 8 Jul 2026 | | Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors | GNW |
| 01/06/26 | 07:00:00 | 1 Jun 2026 | | Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026 | GNW |
| 19/05/26 | 07:14:00 | 19 May 2026 | | Unaudited Preliminary Results for the Year Ended December 31, 2025 | GNW |
| 06/05/26 | 07:00:00 | 6 May 2026 | | Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 | GNW |
| 21/04/26 | 17:00:00 | 21 Apr 2026 | | Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform | GNW |
| 20/10/25 | 07:01:01 | 20 Oct 2025 | | Equity fundraise of £16 million | RNS |
| 20/10/25 | 07:00:09 | 20 Oct 2025 | | Avacta Presents Phase 1a Data for Faridoxorubicin | RNS |
| 13/10/25 | 07:00:12 | 13 Oct 2025 | | Avacta to present data at EORTC-NCI-AACR | RNS |
| 30/09/25 | 07:00:11 | 30 Sept 2025 | | Interim Half Year Results 2025 | RNS |
| 15/09/25 | 07:00:13 | 15 Sept 2025 | | Notice of Interim Results | RNS |
| 09/09/25 | 07:00:17 | 9 Sept 2025 | | Shortlisted for AIM Awards Technology of the Year | RNS |
| 01/09/25 | 07:00:10 | 1 Sept 2025 | | Avacta completes sale of Coris Bioconcept | RNS |
| 29/08/25 | 07:00:09 | 29 Aug 2025 | | Amendments to Convertible Bond + equity fundraise | RNS |
| 30/07/25 | 07:00:12 | 30 Jul 2025 | | Avacta to Present at ESMO Congress | RNS |
| 28/07/25 | 07:48:16 | 28 Jul 2025 | | Agreement to Sell Coris Bioconcept SRL | RNS |
| 21/07/25 | 07:00:08 | 21 Jul 2025 | | Payment of Convertible Bond Installment | RNS |
| 17/07/25 | 07:00:10 | 17 Jul 2025 | | Equity fundraise of £3.25 million | RNS |
| 02/07/25 | 17:00:00 | 2 Jul 2025 | | Result of AGM | RNS |
| 02/07/25 | 07:00:06 | 2 Jul 2025 | | Q2 2025 Business Update | RNS |
| 01/07/25 | 07:00:08 | 1 Jul 2025 | | Management Team Appointments | RNS |
| 30/06/25 | 15:00:01 | 30 Jun 2025 | | Appointment of Zeus Capital as Joint Broker | RNS |
| 19/06/25 | 07:00:09 | 19 Jun 2025 | | New Response in Phase 1b Trial | RNS |
| 09/06/25 | 17:15:59 | 9 Jun 2025 | | Posting of Annual Report and Revised Notice of AGM | RNS |
| 06/06/25 | 07:00:11 | 6 Jun 2025 | | Preliminary Full Year 2024 Results | RNS |
| 04/06/25 | 07:00:10 | 4 Jun 2025 | | Avacta Change in Prelim Date Part 2 | RNS |
| 28/05/25 | 07:00:07 | 28 May 2025 | | Board appointments | RNS |
| 27/05/25 | 07:00:15 | 27 May 2025 | | Update on timing of preliminary results | RNS |
| 15/05/25 | 07:00:12 | 15 May 2025 | | Notice of Results | RNS |
| 12/05/25 | 12:00:00 | 12 May 2025 | | Investor Webinar | RNS |
| 08/05/25 | 07:30:00 | 8 May 2025 | | Block Listing Application to AIM | RNS |
| 29/04/25 | 07:00:12 | 29 Apr 2025 | | Board change | RNS |
| 28/04/25 | 17:52:37 | 28 Apr 2025 | | Block Listing Six Monthly Return | RNS |
| 28/04/25 | 07:01:01 | 28 Apr 2025 | | Avacta presents preclinical data at AACR | RNS |
| 28/04/25 | 07:00:08 | 28 Apr 2025 | | Avacta presents data from lead candidate at AACR | RNS |
| 23/04/25 | 07:00:08 | 23 Apr 2025 | | Issue of Equity and Total Voting Rights | RNS |
| 31/03/25 | 07:00:14 | 31 Mar 2025 | | Avacta Quarterly Update | RNS |
| 26/03/25 | 07:00:09 | 26 Mar 2025 | | Avacta Announces Presentations at AACR | RNS |
| 25/03/25 | 07:00:11 | 25 Mar 2025 | | Avacta Completes Launch Diagnostics Sale | RNS |
| 10/03/25 | 07:00:05 | 10 Mar 2025 | | Avacta to Present at Leerink Healthcare Conference | RNS |
| 07/03/25 | 08:40:57 | 7 Mar 2025 | | Avacta announces data update for AVA6000 | RNS |
| 07/03/25 | 07:42:24 | 7 Mar 2025 | | Avacta to sell Launch Diagnostics | RNS |
| 04/02/25 | 07:00:10 | 4 Feb 2025 | | Appointment of Joint Broker | RNS |
| 21/01/25 | 15:09:46 | 21 Jan 2025 | | Issue of Equity and Total Voting Rights | RNS |
| 16/01/25 | 07:00:05 | 16 Jan 2025 | | Avacta Announces Data from AVA6000 Phase 1 trial | RNS |
| 13/01/25 | 07:00:06 | 13 Jan 2025 | | Avacta Appoints Chief Financial Officer | RNS |
| 12/12/24 | 07:00:05 | 12 Dec 2024 | | Completion of Dose Escalation and RDE Arms | RNS |
